A prospective survey of two hundred patients who received an epidural block in labour was performed in order to determine the incidence and severity of shivering, and the influence of likely associated factors. Twenty-two of the patients who shivered took part in a double-blind trial to see if epidural pethidine 25 mg, versus saline, had any effect upon shivering. Fifty per cent of patients shivered soon after the initial dose of bupivacaine. Shivering was more common among patients who had experienced shivering before epidural block, and in those who had received nitrous oxide (P<0.005). Prior intramuscular injection of pethidine did not significantly affect the incidence of shivering, and it was not influenced by the concentration of epidural bupivacaine used (0.5 or 0.25%). Shiverers were more likely to feel cold than nonshiverers (P<O.OOl) but shivering was generally regarded by patients as a trivial symptom, only 13 % describing it as very irritating. Shivering was abolished or considerably diminished within ten minutes in all patients who received epidural pethidine 25 mg, whereas there was no change in eight out of eleven patients who received epidural saline. These results are significant (P<O.Ol), and demonstrate that shivering following epidural blockade can be effectively treated with small epidural doses of pethidine.
The onset of shivering following epidural analgesia in labour is a relatively common phenomenon, having been reported as occurring in up to 50070 of patients. I ,2 Such shivering is generally regarded as being unimportant, even trivial, although Ostheimer has recently reported that it was the single most disconcerting symptom experienced among a large series of women in labour. 2 Various measures have been suggested to reduce the incidence of shivering such as using warm blankets, preheating epidural and/or ' intravenous solutions to body temperature, I,3 or prescribing drugs such as diazepam or phenothiazines, but none of these remedies appears to have been singularly successful.
During the past five years it has been the author's practice to prescribe epidural pethidine on a patient-demand basis to provide analgesia following caesarean section and other abdominal surgery for up to 48 hours postoperatively. Using this regimen it was noticed that shivering occurred very rarely, if at all. This is in marked contrast to our experience, reported previously, using epidural bupivacaine postoperatively when shivering occurred in one-third of patients, and in 121110 it was described as being severe. 4 The difference in the incidence of shivering between the two drugs appeared to apply equally during labour, being common following bupivacaine and rare after pethidine.
These observations raised the question whether epidural pethidine would lessen shivering which had already become established and thereby serve as a potential remedy. A pilot study indicated that shivering did seem to diminish within minutes of receiving 25 mg epidural pethidine, and often ceased altogether.
It was decided therefore to conduct a survey on the incidence and severity of shivering following epidural analgesia in labour, and to determine the influence of possibly associated factors such as previous analgesia, the dose of bupivacaine used and whether shivering had occurred before neural blockade. None of these factors appears to have been investigated previously. Finally, a double-blind trial was designed to determine the influence of epidural pethidine upon shivering which had already become established.
MATERIALS AND METHODS
A form was designed to survey all patients who received an epidural block in labour. The following information was recorded by the midwife in attendance: 1. whether shivering had occurred before epidural block, 2. analgesic drugs, sedatives and/or nitrous oxide administered before epidural block, 3. the time, concentration and volume of the initial epidural local anaesthetic, 4. whether shivering occurred after the initial dose and at what time, 5. whether the patient felt cold or not, 6. the duration of shivering, and 7. an assessment by the patient of the severity of shivering to one of four categories, q.v.: not bothersome at all, minor nuisance only, very irritating, or unbearable. The initial dose of bupivacaine (10 ml of 0.25 or 0.5070) was given within a five-minute period either via the needle or the epidural catheter.
Some of the patients who shivered were randomly invited to enter a double-blind trial and to receive either pethidine 25 mg in 5 ml preservative-free saline, or saline alone, epidurally. Specially coded vials were prepared for this purpose by the Pharmacy Department and the key, which remained unbroken until the end of the study, was known only to the Chief Pharmacist. The investigation was approved by the Queen Victoria Hospital Research Committee, and informed patient consent was obtained. The coded vial was administered epidurally either by the author or a senior registrar (l.C.) and the influence, if any, on shivering was determined by the patient. Symptoms, which might be attributable to pethidine, such as nausea, vomiting, drowsiness and pruritus, were also noted.
In the survey, differences in the incidence of shivering between groups (e.g. prior pethidine analgesia vs no analgesia) were assessed by a Chi-square test. Patients who shivered prior to the administration of bupivacaine were excluded. Because of the small number of patients in the double-blind study, Fisher's exact test was used to compare the incidence of shivering in the pethidine group with that in the control group.
RESULTS
Two hundred patients were included in the survey, and ninety-nine developed shivering following epidural blockade. It was more commonly observed among those women who had shivered before epidural analgesia (i.e. 20/99) than among those who did not (i.e. 9/101, P < 0.05). These 'pre-block shiverers' were excluded from further statistical analysis. Accordingly, there were 79 patients in whom the onset of shivering appeared to be epiduralrelated (the Shiverers) and 92 patients in whom shivering was not observed following epidural analgesia (the Non-Shiverers).
The onset of shivering, when it occurred de novo, was usually within 15 minutes of the initial dose (48 patients, i.e. 61 %). In the remainder shivering developed later, or the record was not sufficiently complete to be certain of the onset time.
Analgesia received, if any, before epidural blockade is summarised in Table 1 reveals a significant difference in the incidence of shivering and type of analgesia received prior to epidural blockade, X 2 = 12.77 (2 df), P<0.OO5. The null hypothesis, i.e. that shivering is independent of the type of analgesia, can therefore be rejected. The data can be further broken down into two sub-groups to try to identify the source of this lack of independence between the Shiverers and the Non-Shiverers.
First, comparing those who received no analgesia with those who received pethidine, X2 = 0.35 (1 df), P>O.5. Pethidine analgesia did not therefore significantly affect the incidence of shivering. Applying the same test to nitrous oxide, however (i.e. no analgesia versus nitrous oxide), X2 = 9.75 (l df), P<0.005. Thus, Shiverers were significantly more likely to have received nitrous oxide than Non-Shiverers.
The results as to whether, on direct questioning, patients 'felt cold' or not are shown in Table 2 . Shiverers were significantly more likely to symptomatically feel cold that Non-Shiverers.
The concentrations of bupivacaine and its relation to the incidence of shivering is shown in Table 3 .
The incidence of shivering was not associated with the concentration of bupivacaine.
Patients' own assessment of the severity of shivering is reproduced in Table 4 . Shivering was regarded as a relatively trivial symptom, causing distress in only 13070 of those patients who shivered.
Twenty-two patients took part in the doubleblind trial, and the results are shown in Table 5 . Combining the 'reduced' and 'abolished' categories ( Table 5) Fisher's exact test reveals that epidural pethidine significantly reduced or abolished shivering, P<O.Ol (2-tail) . This was usually noticeable within 10 minutes of injection.
Side-effects possibly attributable to pethidine included one patient who felt more drowsy and another who felt nauseated, although in the latter case nausea had also been present before injection. No other symptoms were recorded.
In three of the eleven patients who received epidural pethidine, shivering returned between two and three hours afterwards. On two occasions this appeared to be related to a subsequent dose of epidural bupivacaine. DISCUSSION Shivering can best be described as an involuntary trembling of the body caused by repetitive contraction of opposing skeletal muscle groups. It is most commonly understood as being a physiological response to cold,5 and yet it is well known to occur in other circumstances, quite independently of environmental temperature. In this discussion I have chosen to use the term in its broader descriptive sense irrespective of possible underlying mechanisms.
Shivering has been estimated to occur in approximately 10070 of normal labours. 6 This figure is in close agreement with the incidence of shivering found in the present study before epidural blockade (i.e. 14.5%). The cause of such shivering in labour is unknown, but has been variously ascribed to emotional strain, exertion, hyperventilation, heat loss, intravenous fluids and amniotic emboli. 6 In this survey the incidence of shivering increased significantly following epidural blockade, and was even higher than that reported in previous studies during labour. I . 2 • 3 Almost half of the patients began to shiver, usually within minutes, following the initial dose of bupivacaine. This seemingly temporal association between epidural analgesia and onset of shivering has been noted in other circumstances apart from labour, 7.8 and it is difficult to avoid the conclusion of a causal relationship.
The incidence of shivering related to epidural analgesia may be influenced by other administered drugs. Phenothiazines and diazepam, for example, are known to reduce shivering. Patients who had received these drugs were accordingly excluded from this survey. The influence, if any, of analgesia received in labour prior to epidural blockade on shivering does not seem to have been considered in previous reports.
Pethidine has been shown to inhibit shivering when given intravenously in circumstances other than labour, such as in the recovery period following general anaesthesia 9 • 10 and during the infusion of amphotericin B.II It was anticipated therefore that shivering might also be lessened among patients who had received pethidine in labour. No such association was found here however; shivering being just as common in mothers who received intramuscular pethidine as those who did not. This suggests that any systemic lissive effect of pethidine upon shivering following epidural analgesia in labour is unlikely, although a more detailed investigation would be required to resolve the issue.
There was, however, a significantly higher incidence of shivering, following epidural blockade, among patients who had received nitrous oxide. This observation does not appear to have been recorded previously. Possible mechanisms for such an association between nitrous oxide inhalation and shivering are speculative and will not be discussed further.
Shivering related to epidural analgesia in labour has received very little attention to date, and is presumably regarded as of minor consequence in clinical practice. The majority of patients described in the present survey would support this view -only one in ten describing the symptom as 'very irritating'. This evaluation differs from that of Ostheimer, who reported that shivering was the only disconcerting symptom which occurred in relation to regional anaesthesia in labour. 2 The reason why patients so frequently shiver following epidural blockade remains a mystery. It has commonly been regarded as a response to increased heat loss secondary to sympathetic blockade and cutaneous vasodilation. Bromage has argued, however, that this explanation does not match the observed time-course of events, shivering usually appearing within minutes after injection and long before sufficient time has elapsed for a significant increase in heat loss to have occurred. 12 Nor does it explain why shivering seems to occur so rarely following subarachnoid, as opposed to epidural, blockade (personal observations). Bromage believes that shivering is a spinal cord response secondary to 'misinterpretation' of afferent thermal cues due to a preferential blockade of warm sensation while cold sensation persists. 12 If this hypothesis is correct then it might be expected that the incidence would be influenced by the density of epidural blockade. The present survey, however, revealed no difference in the frequency of shivering and the dose or the concentration of bupivacaine used.
Patients who shivered in the present survey were significantly, although by no means invariably, more likely to 'feel cold' than those who did not shiver. The relevance of this subjective sensation to actual changes in body temperature and to shivering in the context of epidural analgesia is similarly unclear. Differences in environmental temperature for example, or in the volume of intravenous fluids administered between patients may have influenced the incidence of shivering and neither of these factors was considered in th~ present survey. It is unlikely, however, that they were of importance; all patients were managed in a reasonably stable air-conditioned environment, and a previous investigation has already shown that the temperature of intravenous fluids (i.e. pre-warmed versus room temperature) did not significantly alter the incidence of shivering. 3 Neither does the temperature of epidural injectate appear to influence the frequency of shivering,I,3 although one study did show some reduction providing that both bupivacaine and intravenous fluids were warmed to body temperature. 3 In the present study all epidural and intravenous solutions were administered at room temperature.
There seems to be little doubt that whatever the mechanism of epidural-related shivering may be, the principal initiating factor is the actual injection of local anaesthetic agent. The high incidence of shivering following bupivacaine is in marked contrast to that which follows epidural pethidine. With the latter agent, shivering, as noted previously, is remarkable only by its absence. Now it has been shown for the first time that epidural pethidine, 25 mg, reduces shivering which is already established -usually abolishing it altogether within a few minutes.
It is not possible to determine from this study whether the anti-shivering activity of pethidine is primarily a direct opioid-receptor effect at the spinal cord, or whether it is secondary to systemic absorption, or to a combination of both. Parenterally administered pethidine does not appear to have been specifically used as a treatment for shivering in labour, but it has been shown to reduce the incidence of shivering after general anaesthesia when given intravenously.9,1O This property was not shared by equivalent doses of morphine or fentanyl. 9 Recent animal studies have demonstrated the importance of opioid receptors in the shivering response to cold environment. 13 The intraventricular injection of beta-endorphin markedly inhibited cold-induced shivering in anaesthetised rats -an effect which was readily reversed furthermore by naloxone.
The present study has confirmed that shivering following epidural blockade in labour can be readily treated with epidural pethidine 25 mg. It might be useful also to control shivering which occurs so commonly during epidural caesarean section, although this remains to be confirmed. The local anaesthetic dose requirements are greater for surgery than for labour, and the rate of body cooling is more pronounced from, for example, peritoneal exposure and the larger volumes of intravenous fluids used during caesarean section. Epidural pethidine mayor may not be as effective therefore in these circumstances as in labour.
